Creation Technologies Changzhou officially passed the supplier audit of a global top-tier minimally invasive medical device OEM
Release Time:
2026-06-30
In June 2026, Creation Technologies Changzhou officially passed the supplier audit of a global top-tier minimally invasive medical device OEM and became its Approved Location backed by mature medical manufacturing, lean and digital capabilities, facilitating the localized production of high-end medical devices in China.
Milestone: Creation Technologies Changzhou Approved as Approved Location by Global Top-Tier Medical OEM
In June 2026, Creation Technologies Changzhou officially passed the supplier audit of a global top-tier minimally invasive medical device OEM and became an Approved Location. This marks a significant milestone — our China-based manufacturing capability has now been fully validated against the highest standards of a global leading medical OEM.
A Global Benchmark in Minimally Invasive Medicine: Exacting Supply Chain Standards
The auditing party is a global leader in minimally invasive medical devices, with over 15,000 products across interventional cardiology, cardiac rhythm management, peripheral interventions, endoscopy, and urology. The company helps approximately 37 million patients worldwide each year, with annual revenue of $16.7 billion and R&D investment of ~$1.6 billion.
For a company of this caliber, supplier qualification is far from a routine exercise — it is one of the most demanding approval processes in the medical device industry.
The Audit: Rigorous, Systematic, Non-Negotiable
This supplier audit was not a checklist visit. It was a comprehensive, multi-dimensional evaluation covering:
- Quality Management System: Verification of ISO 13485 effectiveness — from documentation to execution, ensuring full-chain consistency;
- Manufacturing & Process Capability: Equipment precision, process control, and ESD protection infrastructure with full traceability;
- Supply Chain Management: Material traceability mechanisms, sub-supplier control systems, and change management processes ensuring every component’s source and destination are verifiable;
- Risk Management: Product risk management framework per ISO 14971 — risk identification and control across the full lifecycle from design transfer to mass production;
- Continuous Improvement: Effectiveness of CAPA (Corrective and Preventive Action) closure, and organizational depth of lean manufacturing and CI culture.
Creation passed every dimension of this audit — from system documentation to floor execution, from personnel competence to equipment readiness — demonstrating the depth and reliability of our medical-grade precision manufacturing system.
From Experience to Competitive Edge: Surgical Robotics & Cardiovascular Intervention
Behind this approval lies years of disciplined accumulation in high-end medical electronics manufacturing.
Surgical Robotics Electronic Consumables: We have been a trusted manufacturing partner for leading global surgical robotics OEMs, delivering force-feedback sensors, high-precision signal acquisition modules, and other critical electronic subassemblies. These products demand exceptional signal integrity, solder joint reliability, and consistency control — requirements we meet through advanced SMT precision processes and 3D AOI full inspection capabilities, achieving sustained high-yield delivery.
Cardiovascular & Surgical Intervention Electronics: In minimally invasive electronic consumables for cardiovascular intervention and endoscopic imaging systems, we have built end-to-end capability spanning PCBA design co-optimization, process engineering, and final inspection. From multi-layer precision lamination of high-frequency signal boards to micro-assembly of minimally invasive consumables, every process undergoes rigorous medical-grade validation.
This hands-on experience across surgical robotics, cardiovascular, and surgical intervention has crystallized into Creation’s unique triad competitive advantage — a medical-grade validated supply chain network, proprietary technical process capabilities, and a team of professionals deeply versed in medical compliance and high-reliability manufacturing.
Automation, Digitalization & Informatization: Technology-Driven Quality & Efficiency
Creation has been continuously investing in automation, digitalization, and informatization, building a solid management foundation for product traceability and in-process quality control. Our full-process MES (Manufacturing Execution System) ensures that every step — from material intake and line-side delivery to finished goods outbound — is traceable, queryable, and controllable. SPC (Statistical Process Control) is embedded across critical workstations, monitoring process stability in real time and shifting quality management from “post-inspection” to “in-process prevention.”
Additionally, Creation has established a Rapid Response system with key suppliers, enabling swift reaction, real-time communication, and efficient coordination when customers require delivery schedule adjustments or order changes — ensuring supply chain agility and more reliable delivery performance for our clients.
Lean Manufacturing & One Piece Flow: Shortest Cycle, Minimal WIP, Optimum Quality
Lean manufacturing is in Creation’s DNA. Our dedicated lean team specializes in designing and deploying One Piece Flow assembly solutions tailored to product characteristics — re-engineering traditional scattered single-station operations into continuous, streamlined production lines where each unit is produced, transferred, and verified one at a time.
The core value of One Piece Flow: Shortest manufacturing cycle time, dramatically compressing the span from raw material release to finished goods; Minimal work-in-process (WIP), eliminating batch quality risks at the source and preventing material accumulation between workstations; Strongest quality assurance, with every unit verified at every station — issues detected and intercepted in real time, ensuring only conforming product advances to the next step.
This deep integration of lean manufacturing capability and professional talent enables Creation to deliver both agile, small-batch rapid fulfillment and consistent, uncompromising quality — exactly what medical-grade, high-reliability products demand.
A New Milestone: Powering Medical Device Localization in China
Becoming an Approved Location for this global top-tier medical OEM signals that Creation Technologies Changzhou has entered a new phase in serving high-end medical OEMs.
For years, the core manufacturing of high-end medical devices has been heavily reliant on overseas facilities. Localized production in China has faced multiple barriers — high compliance thresholds, deep process expertise requirements, and stringent customer audits. Creation is systematically breaking through these barriers: from “shipping for global medical OEMs from China” to “delivering medical-grade manufacturing domestically in China,” we are establishing ourselves as a core manufacturing partner for high-end medical device localization.
This audit approval stands as authoritative validation of Creation’s comprehensive medical manufacturing capabilities — and as a new starting point for deeper engagement with more global top-tier medical OEMs. Moving forward, we will continue to build on lean manufacturing as our backbone and quality compliance as our foundation, contributing reliable manufacturing power to the localization of high-end medical devices in China.
Hyundai
Related News
Add: Building 2, No. 3 Longzi Road, Wujin National Hi-Tech Industrial Zone，Changzhou City, Jiangsu Province,213164 PRC